DK2170304T3 - Bioeroderbar patch - Google Patents

Bioeroderbar patch

Info

Publication number
DK2170304T3
DK2170304T3 DK08762501.8T DK08762501T DK2170304T3 DK 2170304 T3 DK2170304 T3 DK 2170304T3 DK 08762501 T DK08762501 T DK 08762501T DK 2170304 T3 DK2170304 T3 DK 2170304T3
Authority
DK
Denmark
Prior art keywords
bioerodible patch
bioadhesive
bioerodible
patch
bioadhesive layer
Prior art date
Application number
DK08762501.8T
Other languages
English (en)
Inventor
Nigel Crutchley
Steen Sindet-Pedersen
Stephen Lenon
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Application granted granted Critical
Publication of DK2170304T3 publication Critical patent/DK2170304T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
DK08762501.8T 2007-06-26 2008-06-26 Bioeroderbar patch DK2170304T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92939407P 2007-06-26 2007-06-26
EP07252591A EP2008651A1 (en) 2007-06-26 2007-06-26 A bioerodible patch
PCT/GB2008/002197 WO2009001092A1 (en) 2007-06-26 2008-06-26 A bioerodible patch

Publications (1)

Publication Number Publication Date
DK2170304T3 true DK2170304T3 (da) 2011-02-14

Family

ID=38657796

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08762501.8T DK2170304T3 (da) 2007-06-26 2008-06-26 Bioeroderbar patch

Country Status (12)

Country Link
US (1) US9549896B2 (da)
EP (2) EP2008651A1 (da)
JP (1) JP2010531343A (da)
CN (1) CN101730528B (da)
AT (1) ATE490765T1 (da)
AU (1) AU2008269580B2 (da)
CA (1) CA2689572C (da)
DE (1) DE602008003931D1 (da)
DK (1) DK2170304T3 (da)
ES (1) ES2355439T3 (da)
RU (1) RU2460519C2 (da)
WO (1) WO2009001092A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778369B2 (en) * 2005-07-29 2014-07-15 Delaval Holding Ab Barrier film-forming compositions and methods of use
SI2049123T1 (sl) 2006-08-03 2013-04-30 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8501230B2 (en) 2007-12-03 2013-08-06 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
US8822399B2 (en) * 2008-08-28 2014-09-02 Dirty Laundry, Llc Laundry stain and soil pretreatment devices
JP5284070B2 (ja) * 2008-12-12 2013-09-11 救急薬品工業株式会社 口腔内粘膜貼付製剤
TWI494108B (zh) * 2009-01-26 2015-08-01 Nitec Pharma Ag 糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
EP2557947A1 (en) 2010-04-14 2013-02-20 Altria Client Services Inc. Preformed smokeless tobacco product
WO2011153334A2 (en) 2010-06-04 2011-12-08 Trilogic Pharma Llc Bioadhesive compositions for epithelial drug delivery
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
PL2627173T5 (pl) * 2010-10-12 2019-11-29 Chiesi Farm Spa Formulacje emulsyjne klewidypiny zawierające środki przeciw mikrobom
CN103313706A (zh) 2010-11-15 2013-09-18 俄亥俄州立大学研究基金会 控制释放粘膜粘合系统
HRP20191711T1 (hr) * 2011-03-14 2019-12-13 Drug Delivery Solutions Ltd Oftalmološki pripravak
CN102241782B (zh) * 2011-05-18 2013-01-30 清华大学 一种淀粉乙酸酯的制备方法及其在去除水中硝酸盐的应用
US20140186427A1 (en) * 2011-08-12 2014-07-03 Tesa Labtec Gmbh Orodispersible films for the manufacturing of individualised medicine or for large scale production
RU2535095C2 (ru) * 2013-01-09 2014-12-10 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Композиция для трансдермальной доставки в организм лекарственных веществ и лекарственная форма на ее основе
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
CN104606724A (zh) * 2015-01-19 2015-05-13 时恒阳 一种医用导管用润滑剂及其制备方法
KR20240023714A (ko) * 2015-02-02 2024-02-22 산텐 세이야꾸 가부시키가이샤 폴리아프론 및 이의 안검 투여
CA3020157C (en) 2016-04-04 2024-01-16 Drug Delivery Solutions Limited Topical composition comprising tacrolimus
WO2018105779A1 (ko) * 2016-12-07 2018-06-14 서울대학교산학협력단 바이오 패치, 바이오 히터, 바이오 센서, 및 바이오 전자 패치 장치
TWI825013B (zh) 2017-04-19 2023-12-11 日商帝國製藥股份有限公司 含有盧帕他定（ｒｕｐａｔａｄｉｎｅ）之貼附劑
EP3681479B1 (en) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Sodium bicarbonate for use in the treatment of gout and related disorders
RU2662008C1 (ru) * 2017-12-07 2018-07-23 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный аграрный университет имени Н.И. Вавилова" Биоразлагаемое пищевое пленочное покрытие
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2022032395A1 (en) * 2020-08-14 2022-02-17 Ca Pharma Inc. Film with laterally adjoined strip(s) for administration of a vaccine
CN113155987B (zh) * 2020-12-28 2023-06-06 浙江工商大学 一种微针贴片及其制备方法、应用
WO2025169147A1 (en) * 2024-02-08 2025-08-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Sustained-release vaginal films

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
JPS59222409A (ja) 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
CA1272953A (en) 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPH07553B2 (ja) 1985-12-09 1995-01-11 佐藤製薬株式会社 フイルム状製剤
ZA888819B (en) 1987-12-02 1990-07-25 Ici Australia Operations Process for preparing explosive
US4900552A (en) * 1988-03-30 1990-02-13 Watson Laboratories, Inc. Mucoadhesive buccal dosage forms
US4944938A (en) 1988-12-16 1990-07-31 Colgate-Palmolive Company Antiperspirant and deodorant
US4999198A (en) * 1989-03-23 1991-03-12 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Polyaphrons as a drug delivery system
DE69130497T2 (de) 1990-09-07 1999-04-22 Wisconsin Alumni Research Foundation, Madison, Wis. Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
GB9300763D0 (en) 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2710840B1 (fr) 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
FR2719220A1 (fr) 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
US6538039B2 (en) 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
KR0159145B1 (ko) * 1995-02-24 1998-12-01 강박광 피부 약물 전달 체계용 에멀젼 네트웍의 제조방법
CA2220866C (en) * 1995-06-05 2006-11-07 The Dow Chemical Company A process for preparing high internal phase ratio emulsions and latexes derived thereof
US6238678B1 (en) 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
CN1138515C (zh) 1996-03-08 2004-02-18 迪斯珀斯有限公司 包含一种油基双液体泡沫和一种水凝胶的分散体系
US5660858A (en) 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
KR100471341B1 (ko) 1996-05-23 2005-07-21 제네시스 테크놀로지 가부시키가이샤 콘택트프로브및그것을구비한프로브장치
NL1003503C2 (nl) 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
PT1079813E (pt) 1998-04-29 2005-05-31 Virotex Corp Dispositivo transportador farmaceutico adequado para entrega de compostos farmaceuticos as superficies mucosas
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PT3146969T (pt) 1999-04-23 2018-10-18 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
US6200581B1 (en) 1999-04-28 2001-03-13 Dow Corning Corporation Elastomeric silicone terpolymer
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
CN1362873A (zh) 2000-02-22 2002-08-07 彩色通路公司 胶凝的水溶液美容组合物
EP1299494B1 (en) 2000-07-07 2010-08-25 A.V. Topchiev Institute of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
KR100844285B1 (ko) 2000-10-27 2008-07-09 레오 파마 에이/에스 하나 이상의 비타민 ｄ 또는 비타민 ｄ 동족체 및 하나이상의 코르티코스테로이드를 함유하는 국부용 조성물
RU2276177C2 (ru) 2001-05-01 2006-05-10 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Получение гидрофильных, чувствительных к давлению адгезивов с оптимизированными адгезионными свойствами
EP1397132A4 (en) 2001-05-25 2006-12-13 Valley Forge Pharmaceuticals I OPHTHALMIC PIRENZEPINE GEL
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
ATE397902T1 (de) 2001-11-30 2008-07-15 Koninkl Philips Electronics Nv Bildverarbeitungsverfahren und system zum hervorheben von strukturen in verrauschten bildern
GB0214793D0 (en) 2002-06-26 2002-08-07 Disperse Technologies Plc Biliquid foam entrapment
US7053124B2 (en) 2002-11-06 2006-05-30 Disperse Limited Aerosol delivery systems
US20050026877A1 (en) 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
WO2005001643A2 (en) 2003-06-21 2005-01-06 J Maev Jack Ivan Method and apparatus for encouraged visitation web advertising
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
GB0317868D0 (en) 2003-07-30 2003-09-03 Disperse Ltd Biliquid foams with a high alcohol content and products formulated therefrom
GB0317869D0 (en) 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
MXPA06001776A (es) 2003-08-15 2007-09-07 Qlt Usa Inc Sistema de suministro de farmaco transmucosal biocorrosivo, adhesivo.
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
GB0322485D0 (en) * 2003-09-25 2003-10-29 Disperse Ltd Process for the preparation of surface coatings or dry films
JP2005123083A (ja) 2003-10-17 2005-05-12 Dainippon Screen Mfg Co Ltd 塗布組成物および有機ｅｌ素子の製造方法
DE602004012440T2 (de) 2003-11-21 2009-03-26 Galderma Research & Development Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
FR2862540B1 (fr) 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
GB0404403D0 (en) 2004-02-27 2004-03-31 Disperse Ltd Dispersions
FR2871700B1 (fr) 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871698B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
DK1771180T4 (da) 2004-06-17 2011-04-11 Galderma Sa Sammensætning i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase
AU2005253733A1 (en) 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin D derivative in an oily phase
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871699A1 (fr) 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871697B1 (fr) 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871693B1 (fr) 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
AU2005253735A1 (en) 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
FR2871696B1 (fr) 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871694B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
WO2006016869A1 (en) * 2004-07-08 2006-02-16 Drugtech Corporation Delivery system
IT1333365B1 (it) * 2004-09-09 2006-04-11 Alberto Fiorenzi Apparecchiatura e procedimento per realizzare una vela e relativa vela realizzata
AU2005304035B2 (en) 2004-11-09 2010-07-22 Santen Sas Ophthalmic oil-in-water type emulsion with stable positive zeta potential
EP1874320A1 (en) 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
EP2526930B1 (en) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
FR2889662B1 (fr) 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
WO2007120910A1 (en) 2006-04-14 2007-10-25 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The Univ. Of Nevada, Reno Arsenic absorbing composition and methods of use
EP2023918B1 (en) 2006-05-19 2011-03-23 Scynexis, Inc. Cyclosporins for the treatment and prevention of ocular disorders
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970047A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with a corticosteroid
EP1970049A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
EP1970048A1 (en) 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
GB0712389D0 (en) 2007-06-26 2007-08-01 Drug Delivery Solutions Ltd A Pharmaceutical composition
CA2730221C (en) 2007-07-09 2016-02-02 Novagali Pharma Sa Oil in water emulsion comprising nsaids and quaternary ammonium halides
JP2011505409A (ja) 2007-12-04 2011-02-24 ノバガリ ファーマ エスエー パルミチン酸デキサメタゾンのようなコルチコステロイドプロドラッグを含有する眼障害の治療用の組成物
US20110009339A1 (en) 2009-04-14 2011-01-13 Allergan, Inc Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
US20100272875A1 (en) 2009-04-24 2010-10-28 Monsanto Technology Llc Omega-3 enriched cereal, granola, and snack bars
WO2010127301A1 (en) 2009-05-01 2010-11-04 Allergan, Inc. Method of treating allergic conjunctivitis with cyclosporin compositions
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
US8669111B2 (en) 2012-01-24 2014-03-11 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Buffers for stabilizing biological specimens and their use

Also Published As

Publication number Publication date
JP2010531343A (ja) 2010-09-24
ATE490765T1 (de) 2010-12-15
US20100189770A1 (en) 2010-07-29
CA2689572A1 (en) 2008-12-31
AU2008269580A1 (en) 2008-12-31
EP2170304A1 (en) 2010-04-07
DE602008003931D1 (de) 2011-01-20
EP2170304B1 (en) 2010-12-08
RU2010102249A (ru) 2011-08-10
CA2689572C (en) 2016-08-23
ES2355439T3 (es) 2011-03-25
AU2008269580B2 (en) 2013-11-28
CN101730528A (zh) 2010-06-09
CN101730528B (zh) 2017-05-31
WO2009001092A1 (en) 2008-12-31
RU2460519C2 (ru) 2012-09-10
EP2008651A1 (en) 2008-12-31
US9549896B2 (en) 2017-01-24

Similar Documents

Publication Publication Date Title
DK2170304T3 (da) Bioeroderbar patch
GB2445519B (en) Copolymer and polymer light emitting device using the same
TWI317752B (en) Safety-improved electrode by introducing crosslinkable polymer and electrochemical device comprising the same
WO2007081381A3 (en) Spinodally patterned nanostructures
WO2008156294A3 (en) Semiconductor light emitting device and method of fabricating the same
WO2008036357A3 (en) Medical devices having biodegradable polymeric regions with overlying hard, thin layers
DE602007010267D1 (de) Kondensierte polyzyklische polymer, dünner organischer film unter verwendung davon und transistor mit dünnem organischem film
ATE497670T1 (de) Verwaltung von drahtlosen systemen
ZA200709921B (en) Biologically active formulation based on cyclodextrin supramolecular complexes
CL2009000328A1 (es) Forma de dosificacion unitaria que comprende una matriz de pelicula delgada soluble en agua que comprende un copolimero de injerto de polivinilalcohol-polietilenglicol en calidad de polimero de matriz soluble en agua y un estrogeno esteroide como principio activo, en donde la matriz de pelicula tiene un espesor menor a 300 um.
MY151538A (en) Light-emitting device with improved electrode structures
EP2133382A4 (en) POLYMER, AND FILM OR SHEET COMPRISING SAME
WO2008108136A1 (ja) スイッチング素子及びその製造方法
WO2005096744A3 (en) Oriented polymer fibers and methods for fabricating thereof
WO2008083069A3 (en) Bioerodible nano-fibrous and nano-porous conductive composites
WO2007072433A3 (en) Cathode for battery
WO2006087354A3 (en) Insulinotropic agents conjugated with structurally well defined branched polymers
WO2009010842A3 (en) Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009075552A3 (en) Semiconductor light emitting device and method of fabricating the same
MY141131A (en) A sheet for providing a barrier
EP1973724A4 (en) TIRE-EQUALITY CORRECTION WITH SEVERAL HARMONIOUS
WO2009023761A3 (en) Pharmaceutical compositions comprising ropinirole
GB2432837B (en) Polymeric compound, thin polymer film, and thin polymer film element including the same
WO2010068763A3 (en) Endoscopic sheet rolling system
ITMI20060070U1 (it) Mobile con almeno una ribaltina sollevabile,montata sul mobile